Cellect Biotechnology Ltd. (Nasdaq: APOP) to Ring
Post# of 301275
ADVISORY, Feb. 23, 2017 (GLOBE NEWSWIRE) --
What: Cellect Biotechnology Ltd. (Nasdaq: APOP ), a developer of stem cells isolation technology, will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Shai Yarkoni, CEO & Co-Founder and Kasbian Nuriel Chirich – Chairman of the Board and Co-Founder , will ring the Opening Bell.
Where: Nasdaq MarketSite – 4 Times Square – 43 rd & Broadway – Broadcast Studio
When: Friday, February 24, 2017 – 9:15 a.m. to 9:30 a.m. ET
Cellect Biotechnology Media Contact: Eyal Leibovitz - CFO +972-52-2552222 eyal@cellectbio.com
Nasdaq MarketSite: Emily Pan (646) 441-5120 emily.pan@nasdaq.com
Feed Information: Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media: For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: http://www.facebook.com/NASDAQ .
For photos from ceremonies and events, please visit our Instagram page: http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our YouTube page: http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter page: http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our Tumblr page: http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Opening Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of the Market Open, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market open of your choice.
About Cellect Biotechnology Ltd. Cellect Biotechnology is traded on both the NASDAQ and Tel Aviv Stock Exchange (NASDAQ: APOP ) (NASDAQ: APOPW ) (TASE: APOP ). The Company has developed a breakthrough technology for the isolation of stem cells from any given tissue that aims to improve a variety of stem cells applications. The Company’s technology is expected to provide pharma companies, medical research centers and hospitals with the tools to rapidly isolate stem cells in quantity and quality that will allow stems cell related treatments and procedures. Cellect’s technology is applicable to a wide variety of stem cells related treatments in regenerative medicine and that current clinical trials are aimed at the cancer treatment of bone marrow transplantations.
About Nasdaq Nasdaq (Nasdaq: NDAQ ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables clients to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 85 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,800 listed companies with a market value of $10.1 trillion and nearly 18,000 corporate clients. To learn more, visit: business.nasdaq.com .
-NDAQA-
(0)
(0)